Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758797 · ClinicalTrials.gov registry record · Phase 1
A Novel Treatment for Metastatic Melanoma
A Phase 1 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00758797: Clinical Trial Phase 1 study, sponsored by Northwestern University.
NCT00758797 is a Phase 1 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00758797, a Phase 1 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
A novel treatment for metastatic melanoma combining a laser and an immune-system stimulating cream.
Interventions
- OTHER Photoimmunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Why NCT00758797 stopped before completion
NCT00758797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Photoimmunotherapy is the first listed.
NCT00758797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00758797 about?
NCT00758797 is a clinical study titled "A Novel Treatment for Metastatic Melanoma". A novel treatment for metastatic melanoma combining a laser and an immune-system stimulating cream.
What is the current status of trial NCT00758797?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2008-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00758797?
The interventions under investigation include: Photoimmunotherapy (OTHER).
Who is sponsoring clinical trial NCT00758797?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00758797's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia